Gyroscope Therapeutics Holdings plc Aktie
Aktien
VISN
US40382N1037
VISN
Biotechnologie
Manager | Titel | Alter | Seit |
---|---|---|---|
Ian Pitfield
CTO | Chief Tech/Sci/R&D Officer | 58 | 01.07.20 |
Jane Hughes
CTO | Chief Tech/Sci/R&D Officer | 50 | 01.10.19 |
Edward Lang
PRN | Corporate Officer/Principal | 44 | 01.06.19 |
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Director/Board Member | 52 | - | |
Director/Board Member | 51 | - | |
Janet Hopkins
BRD | Director/Board Member | 59 | - |
% 1. Jan. | Kap. | |
---|---|---|
+48,71 % | 56,87 Mrd. | |
+37,15 % | 39,72 Mrd. | |
-6,20 % | 39,27 Mrd. | |
-6,90 % | 28,73 Mrd. | |
+13,37 % | 26,21 Mrd. | |
-16,37 % | 19,79 Mrd. | |
+32,84 % | 12,28 Mrd. | |
+27,98 % | 12,23 Mrd. | |
+0,61 % | 12,12 Mrd. |